NEW YORK, July 29, 2024–(BUSINESS WIRE)–Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat
Asbestos, a group of naturally occurring fibrous minerals, has been historically used for its durability and resistance to heat.
FDA-approved disease modifying treatments include Eisai and Biogen’s Leqembi and Lilly’s newly approved Kisunla. Credits: SewCreamStudio/Shutterstock.com As the industry paints an increasingly clearer picture for
Recently, I was shocked to hear that North Texas is one of the hardest-hit areas of the country for food insecurity. Shocked, but not surprised.
What You Should Know: · QuVa Pharma acquired LogicStream Health, a SaaS software informatics platform for healthcare system pharmacies. · LogicStream, now a wholly owned
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration
Tandem Diabetes Care this year began a full launch of its smallest insulin pump, called Mobi, after the device received clearance from the Food and
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q2 Revenue: 4.46 billion
Research conducted at the University of Gothenburg shows that the physical activities we do as we go about our lives, at work or in the
A study led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Fundación SHE, supported by “la Caixa” Foundation, demonstrates that teaching healthy habits through